BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16933379)

  • 21. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2015 Mar; 90(12):109-20. PubMed ID: 25796641
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pandemic and prepandemic H5N1 influenza vaccines: a 2009 update].
    Loulergue P; Launay O
    Med Sci (Paris); 2009; 25(8-9):719-25. PubMed ID: 19765386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reference viruses for seasonal and pandemic influenza vaccine preparation.
    Wood JS; Robertson JS
    Influenza Other Respir Viruses; 2007 Jan; 1(1):5-9. PubMed ID: 19459278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza virus hemagglutinin--structural studies and their implications for the development of therapeutic approaches.
    Stevens J; Donis RO
    Infect Disord Drug Targets; 2007 Dec; 7(4):329-35. PubMed ID: 18220964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H5N1 vaccine hits the target, but not the bull's eye.
    Sambhara S; Bridges CB; Poland GA
    Lancet Infect Dis; 2007 Aug; 7(8):503-5. PubMed ID: 17646023
    [No Abstract]   [Full Text] [Related]  

  • 26. Aflunov(®): a prepandemic influenza vaccine.
    Gasparini R; Amicizia D; Lai PL; Panatto D
    Expert Rev Vaccines; 2012 Feb; 11(2):145-57. PubMed ID: 22309663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designing vaccines for pandemic influenza.
    Horimoto T; Kawaoka Y
    Curr Top Microbiol Immunol; 2009; 333():165-76. PubMed ID: 19768405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza A (H5N1) pandemic prototype vaccine Fluval.
    Vajo Z
    Expert Rev Vaccines; 2009 May; 8(5):619-24. PubMed ID: 19397418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.
    Zheng D; Yi Y; Chen Z
    Viruses; 2012 Dec; 4(12):3589-605. PubMed ID: 23223214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on the immunogenicity of adeno-vector vaccine against H5N1 influenza A virus].
    Zhang XG; Li KB; Ma J; Wang NF; Zhang XM; Sang YH; Dong J; Xu H; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):97-9. PubMed ID: 20104746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status and progress of prepandemic and pandemic influenza vaccine development.
    Leroux-Roels I; Leroux-Roels G
    Expert Rev Vaccines; 2009 Apr; 8(4):401-23. PubMed ID: 19348557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2016 Mar; 91(11):133-43. PubMed ID: 26995804
    [No Abstract]   [Full Text] [Related]  

  • 33. Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms.
    Luke CJ; Subbarao K
    Expert Rev Vaccines; 2014 Jul; 13(7):873-83. PubMed ID: 24855993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccines: the good, the bad, and the eggs.
    Schultz-Cherry S; Jones JC
    Adv Virus Res; 2010; 77():63-84. PubMed ID: 20951870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are we ready for pandemic influenza H5N1?
    Stephenson I
    Expert Rev Vaccines; 2005 Apr; 4(2):151-5. PubMed ID: 15889987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Avian influenza. Flu virus research yields results but no magic bullet for pandemic.
    Normile D
    Science; 2008 Feb; 319(5867):1178-9. PubMed ID: 18309058
    [No Abstract]   [Full Text] [Related]  

  • 37. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.
    Suguitan AL; McAuliffe J; Mills KL; Jin H; Duke G; Lu B; Luke CJ; Murphy B; Swayne DE; Kemble G; Subbarao K
    PLoS Med; 2006 Sep; 3(9):e360. PubMed ID: 16968127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine preparedness--are we ready for the next influenza pandemic?
    Wright PF
    N Engl J Med; 2008 Jun; 358(24):2540-3. PubMed ID: 18550873
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preclinical studies of live intranasal H5N1 influenza vaccine with the deleted HS1 gene].
    Romanovskaia-Roman'ko EA; Ferko B; VyshemirskiÄ­ OI; Romanova IuR; Krenn B; Muster T; Grudinin MP; Lapin BA; Egorov AIu; Kiselev OI
    Vopr Virusol; 2011; 56(6):19-22. PubMed ID: 22359944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seasonal influenza vaccination may mitigate the potential impact of an H5N1 pandemic.
    Qin CF; Qin ED
    Chin Med J (Engl); 2008 Aug; 121(15):1481-3. PubMed ID: 18959131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.